Antianginal medications are drugs that prevent or relieve angina, the chest pain that occurs when your heart muscle doesn’t get enough oxygen-rich blood. They work by either reducing how hard your heart has to work or by improving blood flow to the heart itself. The three main classes are nitrates, beta-blockers, and calcium channel blockers, with a newer drug called ranolazine offering a fourth option that works through a completely different mechanism.
Why Angina Happens and How These Drugs Help
Angina is a symptom, not a disease. It signals that your heart is temporarily starved for oxygen, usually because one or more coronary arteries have narrowed from plaque buildup. During physical activity or stress, your heart beats faster and needs more oxygen, but those narrowed arteries can’t deliver enough. The result is pressure, squeezing, or pain in your chest that typically fades with rest.
Antianginal drugs tackle this oxygen mismatch from two directions. Some reduce myocardial oxygen demand, meaning they lower your heart rate, blood pressure, or the force of each heartbeat so the heart needs less fuel. Others improve oxygen supply by widening blood vessels to let more blood reach the heart muscle. Most antianginals do some combination of both.
Nitrates: The Fast-Acting Option
Nitrates are the oldest and most recognizable antianginal drugs. Nitroglycerin, available as a tablet you dissolve under your tongue, a mouth spray, or a skin patch, is the classic example. When you take a nitrate, it releases a molecule called nitric oxide inside the walls of your blood vessels, which causes them to relax and widen.
The primary effect is on your veins. Nitrates redirect blood away from the heart into the body’s venous system, reducing the volume of blood flowing back to the heart. With less blood to pump, the heart chambers operate at lower pressures and don’t have to work as hard. Nitrates also relax arteries to some degree, lowering the resistance the heart pumps against. Both effects cut down on oxygen consumption. The most common side effects are headache, dizziness, and a drop in blood pressure.
One important limitation: your body can develop tolerance to nitrates surprisingly fast with continuous use. To prevent this, doctors design dosing schedules that include a 10 to 12 hour nitrate-free window each day, typically overnight when you’re at rest and least likely to need the drug.
Beta-Blockers and Calcium Channel Blockers
Beta-blockers slow your heart rate and reduce the force of each contraction, directly lowering the heart’s oxygen demand. They’re particularly effective during physical exertion, when your heart rate would normally spike. The 2024 European Society of Cardiology guidelines recommend starting most patients on a beta-blocker or calcium channel blocker as first-line therapy for chronic coronary syndromes.
Calcium channel blockers work by preventing calcium from entering the muscle cells in your heart and blood vessel walls. Without that calcium signal, the vessels relax and widen, improving blood flow to the heart while also reducing how hard it pumps. Some calcium channel blockers also slow the heart rate, similar to beta-blockers, while others primarily target the blood vessels. The most commonly reported side effect for both beta-blockers and calcium channel blockers is disturbances in heart rhythm, though this varies by specific drug and dose.
When a single drug isn’t enough, doctors often combine agents from different classes. A beta-blocker paired with a long-acting nitrate, for example, attacks the oxygen imbalance from multiple angles at once.
Ranolazine: A Different Approach
Unlike the three traditional classes, ranolazine doesn’t work by changing your heart rate, blood pressure, or blood vessel size. Instead, it targets what happens inside heart cells during oxygen deprivation. When heart tissue becomes ischemic (oxygen-starved), sodium channels in the cell membranes stay open much longer than normal, flooding the cells with sodium. That sodium buildup triggers a chain reaction: calcium accumulates inside the cells, the heart muscle stiffens during its resting phase, and blood flow through the small coronary vessels worsens.
Ranolazine blocks this abnormal late sodium current, preventing the sodium and calcium overload. The result is improved relaxation of the heart muscle between beats and better coronary blood flow. It’s typically added when beta-blockers and calcium channel blockers alone aren’t controlling symptoms well enough. Large trials have shown it performs comparably to traditional antianginals in reducing chest pain episodes and improving exercise capacity.
Stable vs. Unstable Angina
The way antianginals are used depends heavily on which type of angina you’re dealing with. Stable angina follows a predictable pattern: it shows up during exertion or stress and goes away within minutes of resting or taking nitroglycerin. If your angina is stable, the goal is long-term management with daily medications, lifestyle changes, and a fast-acting nitrate like sublingual nitroglycerin for breakthrough episodes.
Unstable angina is a different situation entirely. The pain comes on without a clear trigger, lasts longer, feels more intense, or occurs at rest. This is a medical emergency that requires hospital treatment, potentially including procedures to physically open blocked arteries. Antianginals still play a role in the acute setting, but they’re part of a broader, more aggressive treatment plan.
A Critical Drug Interaction to Know
If you take nitrates in any form, combining them with erectile dysfunction medications like sildenafil (Viagra) or similar drugs is dangerous. Both drug types cause blood vessels to relax, and together they can trigger a severe, potentially life-threatening drop in blood pressure. This interaction applies whether the nitrate is a daily long-acting pill or a single sublingual tablet taken during a chest pain episode. Even if someone uses an ED medication only occasionally, taking a nitrate within the drug’s active window can cause hemodynamically significant hypotension. This combination carries a labeled contraindication, meaning it should be avoided entirely unless a cardiologist has specifically weighed the risks for an individual patient.
What These Drugs Can and Cannot Do
Antianginals are effective at what they’re designed for: reducing chest pain episodes, improving exercise tolerance, and improving quality of life. All four major drug classes, beta-blockers, nitrates, calcium channel blockers, and ranolazine, have demonstrated equivalent effectiveness at controlling ischemic symptoms in head-to-head comparisons.
What they don’t do is reverse the underlying coronary artery disease. The narrowed or blocked arteries that cause angina remain, which is why antianginal therapy almost always accompanies other treatments: cholesterol-lowering medications to slow plaque progression, blood thinners to reduce clot risk, and lifestyle modifications like exercise, dietary changes, and smoking cessation. For some patients, procedures to physically widen or bypass blocked arteries are also necessary. Antianginals manage the symptom while these other strategies address the disease itself.